Los Angeles Johnson & Johnson Talc Ovarian Cancer Lawsuit: Former FDA Commissioner Says J&J “Misled the FDA” for Over Half a Century
If you are reading this at 2 a.m., you already know the question that keeps you awake: did the powder on the bathroom shelf — the one that smelled like a baby, that came in a bottle you trusted since you were young — cause the cancer that took your mother, your wife, your sister, your daughter? You are not crazy for asking. A Los Angeles jury is hearing testimony right now from the person who once ran the entire FDA, and he is saying, under oath, that Johnson & Johnson knew its talc products were contaminated with asbestos and spent fifty years making sure nobody found out.
We are Attorney911 — The Manginello Law Firm. We handle toxic tort and product liability cases and wrongful death claims, and we built this page for one person: the family member who just heard about this trial and is wondering whether they still have a case. The short answer is: maybe. The honest answer is: it depends on when your loved one died, what medical records survive, and whether anyone acts fast enough to preserve the evidence that is quietly aging out of existence. So let us give you everything — the law, the medicine, the money, the clock, and the playbook the other side is already running — and you can decide from a position of knowledge, not fear.
California’s Strict Products Liability Law: What It Means for Your Family
California is the state that invented modern product liability law. The doctrine — strict products liability — was born in a California Supreme Court case called Greenman v. Yuba Power Products, and it changed the American legal landscape. The core idea is simple and powerful: if a manufacturer puts a defective product into the stream of commerce, and that product causes injury, the manufacturer is responsible — regardless of whether the manufacturer was careful. You do not have to prove negligence. You have to prove the product was defective and it caused the harm.
For a talc ovarian cancer case in Los Angeles, that framework matters enormously. California recognizes two primary product-defect theories that apply here:
Failure to Warn
A product is defective if the manufacturer knew or should have known about a danger and failed to warn consumers. The evidence Dr. Kessler described — internal documents from the 1970s showing knowledge of asbestos contamination, altered test results, a test method known to be inadequate, a secret chemical process to reduce asbestos — goes far beyond what any plaintiff needs to show. This is not a company that should have known. This is a company that did know, and the documents prove it, and the former head of the FDA is saying so under oath.
California law on failure to warn is particularly strong because the duty to warn runs to the consumer — the woman who bought the powder at a grocery store in Los Angeles, who used it for feminine hygiene for years or decades, who had no way of knowing that the bottle contained a substance contaminated with a known human carcinogen. The duty is not satisfied by telling the FDA. The duty is to warn the person who will use the product.
Design Defect
California applies two tests for design defect, and talc plaintiffs typically plead both:
The consumer expectation test asks whether the product performed as safely as an ordinary consumer would expect. No consumer buying baby powder expects it to contain asbestos. No consumer expects it to cause ovarian cancer. The gap between what the product did and what a reasonable consumer would expect is the defect.
The risk-benefit test asks whether the product’s design dangers outweigh its benefits, and whether a safer alternative design was available. Here, the alternative is obvious and was available the entire time: cornstarch-based powder. J&J itself eventually switched to cornstarch in some markets. The risk-benefit test fails for a product contaminated with a known carcinogen when a safe alternative existed and was inexpensive to produce.
Punitive Damages: California Civil Code § 3294
This is where the Kessler testimony does its heaviest lifting. California allows punitive damages — money meant to punish, not just compensate — when a plaintiff proves by clear and convincing evidence that the defendant acted with malice, oppression, or fraud. The statute specifically defines “fraud” as “an intentional misrepresentation, deceit, or concealment of a material fact known to the defendant with the intention on the part of the defendant of thereby depriving a person of property or legal rights or otherwise causing injury.”
Read that definition against the evidence:
- Altering test results before submitting them to the FDA — that is concealment.
- Replacing an unfavorable report with a version that minimized asbestos — that is intentional misrepresentation.
- Advocating for a testing method the company knew was inadequate — that is deceit.
- Telling the FDA in 2016 that no asbestos had ever been found when internal documents showed otherwise — that is a false statement.
California punitive damages are measured by two factors: the reprehensibility of the defendant’s conduct and the defendant’s wealth. Johnson & Johnson is one of the largest pharmaceutical companies on earth, with revenues in the tens of billions. A punitive award scaled to a company of that size — to achieve actual deterrence, not a slap on the wrist — is potentially enormous. The half-century pattern of concealment that Dr. Kessler described is the kind of conduct California’s punitive damages statute was written to punish.
No Damage Caps in Product Liability Cases
This is critical and widely misunderstood. California’s MICRA (Medical Injury Compensation Reform Act) caps non-economic damages — but only in medical professional negligence actions. A product liability case against a pharmaceutical manufacturer is not a medical negligence case. There is no statutory cap on non-economic damages, no cap on punitive damages, and no cap on economic damages in a California product liability verdict. The jury decides what the harm is worth, and the number is whatever the jury says, subject only to the court’s review for excessiveness.
Proposition 51 and Several Liability
California follows a rule called Proposition 51 for non-economic damages: each defendant is responsible only for its proportionate share of non-economic damages (pain and suffering, loss of companionship). For economic damages (medical bills, lost earnings, funeral costs), joint and several liability applies — meaning any defendant can be held responsible for the full economic loss regardless of percentage. In a case where J&J is the primary or sole defendant, Proposition 51 may not significantly affect recovery, but in a multi-defendant case involving McCrone & Associates or talc suppliers, the allocation strategy matters.
The FDA Regulatory Gap and How Johnson & Johnson Exploited It
To understand how this deception lasted fifty years, you need to understand the regulatory hole it was built inside. The FDA regulates cosmetic products — including talc-based powders — under the Federal Food, Drug, and Cosmetic Act. But historically, the FDA’s authority over cosmetics was dramatically limited compared to its authority over drugs and medical devices. There was no mandatory pre-market approval for cosmetics. There was no mandatory asbestos testing requirement. The agency relied largely on post-market enforcement and industry self-reporting.
That regulatory gap is exactly what J&J allegedly exploited. The company offered self-testing assurances in lieu of independent government verification. It convinced the FDA that its internal testing protocols were sufficient. And when the FDA proposed doing its own testing — the 1976 proposal that a J&J executive called “disturbing” — the company’s representations were apparently enough to persuade the agency to back down.
The Modernization of Cosmetics Regulation Act (MoCRA) of 2022 changed this landscape significantly. MoCRA expanded FDA oversight of cosmetics to include facility registration, adverse event reporting, and safety substantiation requirements. But the alleged misconduct in this case predates MoCRA by decades and continued beyond its enactment — the 2016 false letter to the FDA was sent under the old regulatory regime, and the altered test reports date to the 1970s.
The regulatory context matters for the jury because it explains how the concealment was possible. The FDA was not incompetent. The FDA was systematically misled by a company that controlled the testing, controlled the data, and controlled the narrative — and the person telling the jury this is the man who used to run the FDA.
J&J’s own actions in recent years are also telling. In 2019, the company voluntarily recalled certain talc products after FDA testing detected asbestos. In 2020, J&J discontinued talc-based baby powder in the U.S. and Canadian markets. These actions are relevant as pattern-and-practice evidence: a company that truly believed its product was asbestos-free would not need to recall it or pull it from the market.
The Evidence Clock: What Exists and How Fast It Disappears
Every product liability case has evidence that is dying on a clock. In a talc ovarian cancer case, the clock is particularly cruel because the exposure happened decades ago and the evidence of that exposure is scattered across medical records, pharmacy files, product purchase histories, and corporate documents that the defendant controls.
Evidence the Plaintiff Side Must Preserve
Decedents’ medical records. The complete gynecologic oncology treatment record — pathology reports confirming ovarian cancer, surgical reports, chemotherapy administration records, imaging studies, physician notes documenting the course of treatment from diagnosis through death. These records establish the injury, the treatment, the suffering, and the cause of death. Medical providers retain records for varying periods, and after a patient’s death, records can be purged on the provider’s own retention schedule. Obtain complete records immediately.
Pharmacy and purchase records. Proof that the decedent used talc products — and for how long — is essential to establishing dose and duration. Pharmacy records, grocery store loyalty card data, household product receipts, and even photographs of the bathroom shelf can establish the product-use history. Pharmacies may purge purchase histories after seven to ten years. Retailer data may be destroyed even sooner. Secure this evidence now.
Witness statements from family and friends. The people who saw the decedent use the product — a daughter who remembers her mother’s daily routine, a spouse who bought the powder at the store, a friend who shared the bathroom — can testify to the duration, frequency, and route of talc use. Memory degrades. People move. People die. Identify and preserve witness testimony immediately through recorded statements or written declarations.
Evidence the Defendant Side Controls
Internal J&J documents from the 1970s onward. Many of these documents have already been produced through multi-district litigation discovery — the MDL pending in the District of New Jersey has over 68,000 cases consolidated, and the discovery in that proceeding has surfaced the internal memos, test reports, and corporate communications that Dr. Kessler testified about. But discovery in an individual case may surface additional documents, and ensuring complete production — including metadata, document retention policies, and any subsequently discovered or withheld documents — is essential.
McCrone & Associates original and altered test reports. The handwritten “Do Not Use This Report” note and the replacement version with reduced tremolite amounts are the single most powerful pieces of physical evidence in the case. Chain-of-custody integrity and authentication are critical for decades-old physical documents. McCrone personnel who prepared or reviewed the original reports may be deceased or unreachable — prioritizing witness preservation for anyone still alive who was involved in the testing is urgent.
FDA correspondence from J&J (1970s through 2016). The regulatory file — including the 2016 letter asserting “no asbestos-forming structures have ever been found” — is maintained under federal recordkeeping requirements. These records are obtainable through FOIA requests and litigation discovery. The complete regulatory file, including any withdrawn or amended submissions, tells the story of a half-century pattern of false and misleading statements.
J4-1 test methodology documentation. The validation studies and methodology documentation for the test J&J advocated — the one that could not detect chrysotile asbestos or any asbestos below 0.5% — prove that the company knowingly selected an unreliable safety protocol. These documents may be scattered across J&J scientific affairs, regulatory affairs, and outside consultant files.
Chemical asbestos-reduction process records. The documentation of J&J’s chemical method for reducing asbestos in mined talc — including when the process was implemented, what asbestos levels were detected before treatment, and what levels remained after treatment — proves that the company knew the raw material was contaminated and took corrective action without notifying the FDA. Process engineering records, internal communications, and supplier correspondence are targets.
Product samples from relevant manufacturing lots. If product samples from the periods corresponding to decedents’ usage can be located — from J&J retained samples, consumer-returned products, or archival lot samples — independent testing by electron microscopy and X-ray diffraction can identify and quantify asbestos fibers. Historical product samples are rarely retained by manufacturers beyond regulatory requirements, but the search must be made.
Deposition testimony from J&J executives and scientists. The witnesses from the 1970s through 1990s era — the executives who wrote the memos, the scientists who ran the tests, the regulatory affairs personnel who communicated with the FDA — are aging. Some have died. Some are approaching the end of their lives. Every day that passes without their deposition testimony is a day the window closes irreversibly. Prioritizing depositions of all available knowledgeable witnesses is not a luxury; it is a race against mortality.
The Preservation Letter
The day a family contacts a lawyer about a talc ovarian cancer case, a preservation letter — also called a spoliation letter or litigation-hold letter — should go out to every entity that controls relevant evidence: J&J, McCrone & Associates, any identified talc suppliers, the decedent’s medical providers, pharmacies, and retailers. The letter puts these entities on formal notice that evidence must be preserved and that destruction after notice may result in court sanctions, including an adverse-inference instruction telling the jury they may assume the destroyed evidence was as damaging as the plaintiff claims.
In a talc case, the preservation letter is not a formality. It is the single most important pre-suit action because the evidence that proves the case — the internal documents, the test reports, the corporate communications — is in the defendant’s possession, and the defendant has a demonstrated fifty-year pattern of concealing unfavorable information.
The Insurance Playbook and How We Counter It
J&J does not fight these cases the way an ordinary defendant does. It fights like a Fortune 50 corporation with unlimited legal resources, a coordinated national defense strategy, and fifty years of experience managing the narrative. Here is what to expect — and how each play is countered.
Play 1: The Causation Smokescreen
What they do: J&J will bring in epidemiologists and oncologists to argue that ovarian cancer is a complex disease with many causes — BRCA mutations, family history, reproductive factors, hormone therapy — and that the plaintiff cannot prove talc caused this particular cancer. They will emphasize the studies that show weak or no association and minimize the studies that show a statistically significant link.
How we counter: The altered test reports and the concealed asbestos contamination change the causation calculus. The defense wants to argue about talc alone; the evidence shows the product contained asbestos — a Group 1 carcinogen. A gynecologic oncologist ties the specific decedent’s cancer to the exposure pathway and the dose. An epidemiologist presents the full body of associational studies. And the concealment evidence — proving the company knew its product was more dangerous than the scientific literature assumed — undermines every defense argument that relies on the company’s own prior safety representations.
Play 2: The Bankruptcy Freeze
What they do: J&J has demonstrated, three times, a willingness to use bankruptcy to freeze all talc litigation and force claims into a trust that pays fractions of their value. A new bankruptcy filing could stay every pending case, including one in Los Angeles.
How we counter: Monitoring the bankruptcy posture is essential. If a new filing occurs, counsel must be prepared to object to the stay, argue against the appropriateness of the bankruptcy, and protect the client’s right to a jury trial. Three courts have already rejected this strategy — the legal precedent for challenging a fourth attempt is strong. But the family needs a lawyer who is watching this and ready to act.
Play 3: The “Ancient Documents” Defense
What they do: J&J will argue that the 1970s documents are ancient history — that current executives had nothing to do with decisions made fifty years ago, that corporate practices have changed, and that punishing the company today for conduct in the Nixon administration is unfair.
How we counter: The 2016 letter. The false statement to the FDA — “no asbestos-forming structures have ever been found” — was sent under the current corporate structure. The concealment is not ancient; it is continuous. Dr. Kessler’s testimony frames it as a single, unbroken pattern from the 1970s through 2016. The jury sees not a historical error but an institutional culture.
Play 4: The Global Settlement Squeeze
What they do: J&J may offer a global settlement program — a fund that pays all claimants according to a matrix, with amounts calibrated to the severity of injury and the strength of the claim. The offer will be structured to make individual litigation seem risky and slow by comparison.
How we counter: A settlement can be the right outcome — but only if the family understands what their case is actually worth and what they are giving up. The matrix value may be a fraction of what a Los Angeles jury would return. The family needs counsel who can evaluate the settlement against the trial value, negotiate individually, and go to trial if the number is wrong.
Play 5: The Surveillance and Social Media Mining
What they do: J&J’s investigators will monitor the plaintiffs’ and family members’ social media, public records, and any available surveillance to find evidence that contradicts the claimed damages — a photo of the decedent looking healthy, a family member’s post that minimizes the suffering, any inconsistency between the claimed loss and the public record.
How we counter: We tell every client from day one: assume you are being watched. Do not post about the case. Do not post about the family’s grief. Do not post about the decedent’s health before death. The surveillance is legal; the only defense is not giving them anything to use.
Play 6: The Learned-Intermediary and Regulatory-Compliance Arguments
What they do: J&J may argue that it complied with all applicable FDA regulations, that the FDA never required asbestos testing, and that the company cannot be held liable for failing to warn about a danger the regulatory framework did not require it to address.
How we counter: California’s strict products liability doctrine does not let a manufacturer hide behind regulatory compliance. The Greenman standard imposes liability for defective products regardless of whether the manufacturer followed all government rules. And the evidence shows J&J did not merely fail to go beyond the regulatory floor — it actively subverted the regulatory process by altering test results and making false statements to the agency. A company that manipulates the regulator cannot then claim the regulator’s inaction as a defense.
Your First Steps: The 72-Hour Roadmap
If you are reading this because you lost a loved one to ovarian cancer and she used J&J talc products, here is what to do — and what not to do — in the next 72 hours.
Do This
Write down everything you remember about her talc use. What brand. What product (baby powder, Shower to Shower). How often she used it. How many years. Where she bought it. Whether she used it for feminine hygiene. This is the product-use history, and your memory is the single most important piece of it. Write it down now, while the memories are fresh, even if you are not sure about a lawsuit. Dates, brands, frequency, and route of application are the foundation of the case.
Gather medical records. If you have access to your loved one’s medical records — pathology reports, surgical records, chemotherapy records, physician notes, the death certificate — gather them. If you do not have them, note where they are: which hospital, which oncologist, which hospice. We will help you request them, but knowing where they are saves critical time.
Locate any product containers or receipts. If there is still a bottle of J&J talc powder in the bathroom, on a shelf, in a closet — do not throw it away. It is evidence. If there are old receipts, loyalty card records, or photographs showing the product in the home, preserve them.
Talk to family members who can corroborate. Brothers, sisters, children, spouses, close friends — anyone who saw her use the product or knew about her routine. Their memories are evidence too, and memories fade.
Call a lawyer. The consultation is free. We will tell you whether the statute of limitations has run, whether the discovery rule may save the case, what evidence we need, and what the process looks like. You do not have to decide whether to file a lawsuit on the first call. You just need to know your rights before the clock runs out further.
Do Not Do This
Do not sign anything from J&J or any claims administrator. If you receive a letter, a form, or a settlement offer from J&J, from a claims facility, or from anyone purporting to represent the talc settlement program — do not sign it, do not return it, and do not cash any check that comes with it. Signing a release can extinguish your claim permanently.
Do not give a recorded statement to anyone. If an insurance adjuster, an investigator, or anyone representing J&J contacts you and asks you to “just tell us what happened” on a recording, decline. That recording is built to be used against you.
Do not post about the case on social media. Assume the defense is watching. Do not post about your loved one’s death, about the cancer, about J&J, about the lawsuit, about anything related. The only safe post is no post.
Do not wait. California’s wrongful death statute of limitations generally runs two years from the date of death. If your loved one died more than two years ago, the discovery rule — the argument that you did not know and could not have known the cancer was connected to talc — may be the only way to keep the case alive. But the discovery rule is not automatic; it requires legal analysis and, usually, a filing. Every day you wait is a day the defense will argue you should have known sooner.
Frequently Asked Questions
Can I sue Johnson & Johnson if my loved one died of ovarian cancer after using talc products?
You may be able to, yes. A wrongful death claim in California requires proving that the product was defective (through failure to warn or design defect), that your loved one used the product, and that the product caused or contributed to the ovarian cancer. The evidence emerging from the Los Angeles trial — former FDA commissioner testimony about asbestos concealment, altered test reports, and false statements to regulators — strengthens the failure-to-warn and punitive damages elements significantly. The specific causation question (whether talc caused this particular cancer) requires medical and expert analysis, but the concealment evidence is a powerful liability tool. Contact a lawyer for a case-specific evaluation.
How long do I have to file a talc ovarian cancer lawsuit in California?
California’s statute of limitations for wrongful death actions generally runs two years from the date of death. However, the discovery rule — which delays the start of the clock until you knew or should have known that the cancer was connected to talc — may apply if you only recently learned about the asbestos contamination and corporate concealment. Fraudulent concealment by the defendant may also toll the deadline. Do not assume it is too late without speaking to a lawyer; the consultation is free.
What did the former FDA commissioner say about Johnson & Johnson and asbestos?
Dr. David A. Kessler, who served as FDA Commissioner from 1990 to 1997, testified to a Los Angeles jury that J&J “misled the FDA for over the last half century.” He described internal documents from the 1970s showing that J&J and its consultant McCrone & Associates altered asbestos test results before submitting them to the FDA, that J&J advocated for a testing method (the J4-1 test) that it knew could not detect chrysotile asbestos or any asbestos below 0.5%, that J&J used a chemical method to reduce asbestos in mined talc without telling the FDA, and that a 2016 J&J letter to the FDA claiming “no asbestos-forming structures have ever been found” was untrue.
Does California have damage caps in talc cancer lawsuits?
No. California’s MICRA statute caps non-economic damages only in medical professional negligence actions — not in product liability or toxic tort cases. There is no statutory cap on compensatory damages (economic or non-economic) or punitive damages in a product liability verdict against a pharmaceutical manufacturer. The jury determines the amount based on the evidence.
What evidence is needed to prove a talc ovarian cancer case?
The core evidence includes: (1) medical records documenting the ovarian cancer diagnosis, treatment, and cause of death; (2) evidence of the decedent’s talc product use — brand, duration, frequency, route of application — from family testimony, pharmacy records, purchase histories, and household evidence; (3) internal J&J documents showing knowledge of asbestos contamination and concealment from the FDA (many already produced in the MDL); (4) expert testimony on specific causation, exposure pathway, and epidemiology; and (5) economic documentation of medical expenses, lost earnings, and funeral costs. The preservation letter — sent the day you hire a lawyer — is what freezes the evidence before it can be destroyed.
How much is a talc ovarian cancer wrongful death case worth?
Case value depends on the specific facts: the duration and frequency of talc use, the decedent’s alternative risk factors, the strength of the causation evidence, the venue, and the punitive damages potential. Based on the verified case intelligence for three ovarian cancer wrongful deaths with former FDA commissioner testimony and a half-century pattern of regulatory deception, the estimated range is approximately $30 million on the low end to over $300 million on the high end. Punitive damages — driven by the fraud evidence — are the primary upward value driver. The largest affirmed talc verdict in U.S. history was approximately $2.12 billion (originally $4.69 billion, reduced on appeal, affirmed when the U.S. Supreme Court declined review). Past results depend on the facts of each case and do not guarantee future outcomes.
What if my loved one used talc products decades ago?
That is typical for these cases. Talc products were used for feminine hygiene over years or decades, and ovarian cancer has a long latency period. The fact that the use occurred decades ago does not bar a claim — in fact, long-term, frequent use is stronger evidence of exposure. The challenge is preserving evidence of that use: family memories, purchase records, and household evidence. Write down everything you remember now, before memories fade further.
Has Johnson & Johnson tried to limit lawsuits through bankruptcy?
Yes — three times. J&J used a legal maneuver called a “Texas Two-Step” to create a subsidiary (first LTL Management LLC, then Red River Talc LLC) that held only the talc liability and filed for Chapter 11 bankruptcy. Each attempt was designed to freeze all talc lawsuits and force claims into a trust paying reduced amounts. All three attempts were dismissed by courts — the most recent on March 31, 2025. The cases are back in the tort system, but J&J may attempt a fourth filing or pursue a global settlement. Any family considering a claim needs counsel who is monitoring this strategy.
I was diagnosed with ovarian cancer myself and used talc products. Can I still file a claim?
Yes — a personal injury claim (as opposed to a wrongful death claim) may be available if you are the person who was diagnosed. The statute of limitations for personal injury in California generally runs two years from the date you discovered or should have discovered the injury and its cause. If you are currently in treatment or recently diagnosed, contact a lawyer immediately. Your medical records are the most current and complete evidence available, and your own testimony about product use is the strongest form of product-use evidence.
What makes the Los Angeles venue important for a talc case?
Los Angeles County Superior Court is historically one of the most plaintiff-advantageous forums in the nation for product liability and toxic tort litigation. California’s strict products liability doctrine — which imposes liability on manufacturers for defective products without requiring proof of negligence — was pioneered in this state. Los Angeles juries have demonstrated a willingness to return significant verdicts against pharmaceutical and consumer product manufacturers, particularly where corporate concealment evidence is strong. The jury pool is large, diverse, and often skeptical of corporate defendants — and the absence of damage caps in product liability cases means the jury’s award is not artificially limited by statute. Complex civil litigation of this magnitude is typically handled at the Stanley Mosk Courthouse or the Central Civil West courthouse in Los Angeles.
The Bottom Line
A former FDA commissioner told a Los Angeles jury that Johnson & Johnson “misled the FDA for over the last half century.” He described altered test results, a deliberately inadequate testing method, a secret asbestos-reduction process, and a false statement to the agency as recent as 2016. Three women are dead of ovarian cancer. The company tried to send every talc lawsuit in America into a bankruptcy it manufactured for that purpose — three times — and three times a court threw it out.
If your family lost a mother, a wife, a sister, or a daughter to ovarian cancer, and she used Johnson & Johnson talc products for feminine hygiene, the evidence emerging from this trial may be the confirmation of what you already suspected. The question is whether you still have time to act — and the answer depends on facts we can evaluate in a single phone call.
The call is free. The consultation is free. The fee is contingency — we do not get paid unless we win. The number is 1-888-ATTY-911. We answer 24 hours a day, 7 days a week, in English or in Spanish.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential. But the clock on your rights is running, and the evidence that would prove your case is aging. The day you call is the day the clock starts working for you instead of against you.
Call 1-888-ATTY-911. Or contact us online. We are ready.
Attorney911 — The Manginello Law Firm, PLLC. Legal Emergency Lawyers™.